StockWatch
·
Pharmaceuticals
Rights Issue26 Oct 2026, 07:12 pm

Vineet Laboratories: No Deviation in Rights Issue Fund Use for June 30, 2026

AI Summary

Vineet Laboratories Limited has filed a statement confirming no deviation or variation in the utilization of funds raised through its Rights Issue as of June 30, 2026. The company raised ₹2996.81 Lakhs (₹29.97 Crore) between January 1 and January 30, 2026. The funds were allocated for repayment of bank loans (₹284 Lakhs), setting up an effluent treatment plant (₹270 Lakhs), expansion of business by setting up a new production facility (₹1695.35 Lakhs), and general corporate purposes (₹670.83 Lakhs). The report indicates that the utilization for these purposes aligns with the original allocation, with no significant deviations noted for the quarter.

Key Highlights

  • No deviation reported in the utilization of Rights Issue proceeds as of June 30, 2026.
  • Total funds raised via Rights Issue amounted to ₹2996.81 Lakhs (₹29.97 Crore).
  • Allocations included loan repayment, effluent plant, business expansion, and general corporate purposes.
  • Utilization aligns with original fund allocation as per the statement.